Triethylamine → HCID 178493291, compound

HRID 1157285Notes

Reaction equation

HRID 1157285 reaction equation
[C:1]([C:4]([C:6]1[C:14]2[C:9](=[N+:10]([O-:17])[CH:11]=[CH:12][C:13]=2[O:15][CH3:16])[NH:8][CH:7]=1)=[O:5])([OH:3])=O.C(N(CC)CC)C.[C:25]1([N:31]2[C:35]([N:36]3[CH2:41][CH2:40][NH:39][CH2:38][CH2:37]3)=[N:34][N:33]=[N:32]2)[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F>CN(C=O)C.O>[CH3:16][O:15][C:13]1[CH:12]=[CH:11][N+:10]([O-:17])=[C:9]2[NH:8][CH:7]=[C:6]([C:4](=[O:5])[C:1](=[O:3])[N:39]3[CH2:40][CH2:41][N:36]([C:35]4[N:31]([C:25]5[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=5)[N:32]=[N:33][N:34]=4)[CH2:37][CH2:38]3)[C:14]=12

Participants

7

Procedure

A mixture of the solid containing 3-(carboxycarbonyl)-4-methoxy-1H-pyrrolo[2,3-b]pyridine 7-oxide from above (200 mg, 0.84 mmol), triethylamine (0.5 mL, sssss), 1-(1-phenyl-1H-tetrazol-5-yl)piperazine (234 mg, 1.01 mmol) and TBTU (404 mg, 1.26 mmol) was stirred at rt in DMF (1 mL) for 24 h. H2O was added and the reaction mixture was concentrated under reduced pressure. The residue was purified using reverse phase prep HPLC to afford the title compound as a white solid (15 mg, 4%). 1H NMR (500 MHz, CDCl3) δ ppm 3.32 (s, 2 H) 3.37 (s, 2H) 3.56 (s, 2 H) 3.79 (s, 2 H) 4.13 (s, 3 H) 6.83 (d, J=7.32 Hz, 1 H) 7.53 (d, J=6.71 Hz, 1 H) 7.54-7.60 (m, 3 H) 8.16 (s, 1 H) 8.34 (d, J=6.71 Hz, 1H). LCMS: m/e 449 (M+H)+, ret time 0.99 min (method 2).

Workup

  1. additionA mixture of the solid
  2. concentrationthe reaction mixture was concentrated under reduced pressure
  3. customThe residue was purified

Sources & evidence

ORD record
ord-02821634b9574fa48fd735185f22a565
Source dataset
uspto-grants-2010_10
Patent number
US07807671B2

Reaction notes

Loading…